Total planned funding: $139,238,813
Allocations
Countries/Regions
| Democratic Republic of the Congo | $139,238,813 |
Organizational Types
| Private Contractor | $79,404,782 |
| NGO | $31,057,294 |
| University | $16,924,680 |
| Own Agency | $7,153,265 |
| Unknown | $2,400,509 |
| FBO | $1,810,893 |
| Other USG Agency | $477,390 |
| Implementing Agency | $10,000 |
| Multi-lateral Agency | $0 |
Program Areas
| Treatment | $139,238,813 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $67,113,741 |
| HTXS: Treatment: Adult Treatment | $57,684,561 |
| PDTX: Treatment: Pediatric Treatment | $14,440,511 |
Top Partner Programs
Chemonics International:
$78,004,782
Countries/Regions
Democratic Republic of the Congo
| 2017 | $16,224,377 |
| 2018 | $13,405,862 |
| 2019 | $22,054,749 |
| 2020 | $26,319,794 |
Columbia University:
$15,471,519
Countries/Regions
U.S. Centers for Disease Control and Prevention:
$3,427,786
Countries/Regions
Democratic Republic of the Congo
| 2009 | $40,000 |
| 2013 | $76,034 |
| 2019 | $164,623 |
| 2020 | $3,147,129 |